Coronary artery disease in HIV-infected subjects: Results of 101 coronary angiographies;Koronare herzerkrankung bei HIV-infizierten personen: Ergebnisse von 101 koronarangiographien

Herz

Volumn 36, Issue 1, 2011, Pages 18-22

  Neumann, T ^a   Lulsdorf K A ^a   Krings, P ^a   Reinsch, N ^a   Erbel, R ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Antiretroviral therapy; Arteriosclerosis; Coronary artery disease; HIV

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTERIOSCLEROSIS; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; HYPERTENSION; INVASIVE PROCEDURE; MALE; SMOKING;

ADULT; AGED; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; GERMANY; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 79952699056     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-010-3410-7     Document Type: Article

References (26)

1. Robert Koch-Institut (Hrsg) (2010) HIV-Infektionen und AIDS-Erkrankungen in Deutschland. Epidemiologisches Bulletin 46/2010
2. Autran B, Gorin I, Leibowitsch M et al (1983) AIDS in a Haitian woman with cardiac Kaposi's sarcoma and Whipple's disease. Lancet 1:767-68 (Pubitemid 13161344)
3. Hoffmann C, Rockstroh JK, Kamps S (2005) HIV.NET, 3. Aufl. Steinhäuser, Wuppertal-Beyenburg
4. Neumann T, Ross B, Hengge UR et al (2002) Cardiac manifestations in HIV-infected individuals. Med Klin 97:659-665
5. Friis-Moller N, Sabin CA, Weber R et al (2003) Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349:1993-2003
6. Hoffmann C (2005) Premature arteriosclerosis in HIV-infected patients. Herz 30:467-471
7. Behrens G (2005) Metabolic syndrome and hyperlipidemia in HIV-positive patients. Herz 30:458-466 (Pubitemid 41367136)
8. Neumann T, Esser S, Potthoff A et al (2007) Prevalence and natural history of hHeart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study. Eur J Med Res 12(6):243-248 (Pubitemid 47248964)
9. Boy O, Hahn S, Kociemba E (2010) Koronarangiographie und Perkutane Koronarintervention (PCI), Veröffentlichung der BQS-Fachgruppe Kardiologie, Institut für Qualität und Patientensicherheit (BQS), http://www.bqs.de
10. Fischer SD, Lipshultz SE (2001) Cardiovascular abnormalities in HIV-infected individuals. In: Braunwald E (Hrsg) Heart disease: a textbook of cardiovascular medicine. Saunders, Philadelphia, S 2211-2221
11. Neumann T, Reinsch N, Neuhaus K et al (2009) BNP in HIV-infected patients. Herz 34:634-640
12. Friis-Møller N, Reiss P, Sabin CA et al (2007) Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 356(17):1723-1735 (Pubitemid 46658704)
13. Klein D, Hurley LB, Quesenberry CP Jr et al (2002) Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr 30(5):471-477
14. Aoun S, Ramos E (2000) Hypertension in the HIV-infected patient. Curr Hypertens Rep 2:478-481
15. Barbaro G (2003) Pathogenesis of HIV-associated heart disease. AIDS 17:12-20
16. Neumann T, Woiwod T, Neumann A et al (2003) Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients. Part I: Differences due to the acquisition of HIV-infection. Eur J Med Res 8:229-235
17. Neumann T, Woiwod T, Neumann A et al (2004) Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients. Part II: Gender differences. Eur J Med Res 9:55-60
18. Hsue PY, Giri K, Erickson S et al (2004) Clinical features of acute coronary syndromes in patients with human immunodeficiency virus Infection. Circulation 109:316-319 (Pubitemid 38133896)
19. Gohlke H, Albus C, Gysan DB et al (2009) Cardiovascular prevention in clinical practice (ESC and German Guidelines 2007). Herz 34:4-11
20. Asztalos BF, Schaefer EJ, Horvath KV et al (2006) Protease inhibitor-based HAART, HDL and CHD-risk in HIV-infected patients. Atherosclerosis 184:72-7 (Pubitemid 41721071)
21. Riddler SA, Smith E, Cole SR et al (2003) Impact of HIV infection and HAART on serum lipids in men. JAMA 289:2978-2982 (Pubitemid 37430100)
22. Iloeje UH, Yuan Y, Litalien G et al (2005) Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients. HIV Med 6:37-44 (Pubitemid 40268115)
23. Holmberg SD, Moorman AC, Williamson JM et al (2002) Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 360:1747-1748 (Pubitemid 35447907)
24. Rickerts V, Brodt H, Straszewski S et al (2000) Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study. Eur J Med Res 5:329-333
25. Bozzette SA, Ake CF, Tam HK et al (2003) Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 348:702-10 (Pubitemid 36237039)
26. El Sadr WM, Lundgren JD, Neaton JD (2006) CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 355:2283-2296 (Pubitemid 44837777)